The 20 Best Cutaneous T-Cell Lymphoma (CTCL) Doctors Near Me in Michigan, US

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Alexandra Hristov is a Hematologist and a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Hristov is rated as a Distinguished provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Hristov is board certified in Dermatopathology, Pathology-Anatomic/Pathology-Clinical, and Hematopathology.

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as a Distinguished provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

John Runge is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Runge is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Sezary Syndrome, and Lymphomatoid Papulosis.

Erin Pettijohn is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 15 years. Dr. Pettijohn is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

David Byrd is a Dermatologist practicing medicine in Rochester Hills, Michigan. He has been practicing medicine for over 30 years. Dr. Byrd is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Actinic Keratosis, and Warts. Dr. Byrd is board certified in American Board Of Dermatology and American Board Of Dermatology. Dr. Byrd is currently accepting new patients.

Brett Brinker is a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 26 years. Dr. Brinker is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brinker is currently accepting new patients.

Thomas Gribbin is an Otolaryngologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 45 years. Dr. Gribbin is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, and Bone Marrow Aspiration. Dr. Gribbin is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Gribbin is currently accepting new patients.

Edmund Paloyan is an Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 34 years. Dr. Paloyan is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Breast Cancer, and Lynch Syndrome. Dr. Paloyan is board certified in American Board Of Internal Medicine. Dr. Paloyan is currently accepting new patients.

Latha Polavaram is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 27 years. Dr. Polavaram is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 73 other conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Polavaram is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Polavaram is currently accepting new patients.

Dr. Allison Billi is an assistant professor in the University of Michigan Department of Dermatology. Her research aims to define how the skin contributes to systemic autoimmune disease through identifying female-biased pathways and factors in skin that are critical to autoimmunity. In addition, she provides medical dermatology care to patients of all ages within our outpatient clinic at Domino’s Farms.Dr. Billi is a graduate of the University of Michigan Medical School where she received her medical degree and her PhD in Human Genetics. Following graduation, she completed her transitional year at Beaumont Hospital in Dearborn, Michigan, and a dermatology residency and post-doctoral research fellowship at the University of Michigan Department of Dermatology. Dr. Billi is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Psoriasis, Lichen Planus, and Actinic Keratosis. Dr. Billi is board certified in Dermatology.

Britni Mashni is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 11 years. Dr. Mashni is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Triple-Negative Breast Cancer. Dr. Mashni is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Mashni is currently accepting new patients.

Benjamin Gielda is a Radiation Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 20 years. Dr. Gielda is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, Familial Prostate Cancer, and Gamma Knife Radiosurgery. Dr. Gielda is board certified in American Board Of Radiology. Dr. Gielda is currently accepting new patients.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

John Miner is a Dermatologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 37 years. Dr. Miner is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Cheilitis Glandularis. Dr. Miner is board certified in American Board Of Dermatology. Dr. Miner is currently accepting new patients.

William Fabricius is an Otolaryngologist and a Hematologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 24 years. Dr. Fabricius is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Inflammatory Breast Cancer. Dr. Fabricius is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Fabricius is currently accepting new patients.

Mohammad Alhyari is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 18 years. Dr. Alhyari is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Alhyari is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Alhyari is currently accepting new patients.

Adil Akhtar is a Palliative Medicine specialist and an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 41 years. Dr. Akhtar is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Akhtar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Akhtar is currently accepting new patients.